Personalized vitamin D supplementation -- often requiring 5,000 IU of vitamin D each day -- did prove to have secondary ...

Preclinical data with a gene therapy has shown potential to restore cardiac function in a rat model of for heart failure.

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the ...

CRISPR Therapeutics' CTX310 trial shows strong, sustained lipid reductions and favorable safety, boosting confidence in its ...

Jayden Wilsey was the first person at Boston Children's Hospital to receive human gene therapy for sickle cell disease after ...

Bioengineers at Rice University have developed a nonsurgical method to control seizure-related brain activity using sound ...

A report on gene-editing drugs renews debate around long-term statin use as Indian cardiologists caution that risk assessment ...

The LEGEND trial showed a 62% complete response (CR) rate with the non-viral gene therapy at six months in NMIBC patients who ...

Dyno Therapeutics unveils best-in-class Dyno-bn8 AAV vector for muscle gene therapies, achieving therapeutic delivery with improved safety potential ...

A new international study led by Tel Aviv University researchers may pave the way for an effective treatment for amyotrophic ...

Gene anticipates filing a biologics licence application (BLA) for detalimogene voraplasmid to the FDA in H2 2026.